Shree Pacetronix Board Meeting Scheduled on May 25, 2026 to Approve FY26 Audited Financial Results

Shree Pacetronix Limited has notified the BSE of its upcoming board meeting, in compliance with Regulation 29(1) and (2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting, designated as the 01st/2026-2027 Board Meeting, is scheduled for Monday, 25th May, 2026, at 03:00 PM, at the company's registered office located at Plot No. 15, Sector-II, Industrial Area, Pithampur, District Dhar, Madhya Pradesh – 454775.

Key Agenda Items

The board will convene to transact several significant businesses during the meeting. The following matters have been formally listed on the agenda:

Agenda Item:	Details
Financial Results Approval:	Standalone & Consolidated Audited Financial Results for Q4 and FY ended March 31, 2026
Auditor's Report:	To take on record the Statutory Auditor's Report with modified/unmodified opinion for Q4 and FY ended March 31, 2026
Financial Statements Approval:	Standalone & Consolidated Audited Financial Statements including Balance Sheet, Statement of Profit and Loss, and Cash Flow Statement for FY ended March 31, 2026
Other Business:	Any other business matter with the permission of the Chair

Trading Window Closure

In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct for regulating, monitoring, and reporting of trading by insiders, the trading window for dealing in the company's securities has been closed. The closure applies to Designated Persons, including:

Directors
Promoters
Key Managerial Personnel (KMPs)
Designated Employees and Connected Persons
Immediate relatives of the above
Material Subsidiary of the Company

The trading window closure commenced from 1st April, 2026, and will remain in effect until 48 hours after the announcement and declaration of the standalone and consolidated audited financial results for the quarter and financial year ended March 31, 2026. This closure was originally disclosed to the stock exchange vide the trading window closure disclosure dated 26th March, 2026.

Company Background

Shree Pacetronix Limited, incorporated under CIN No. L33112MP1988PLC004317, is a Madhya Pradesh-based company with over 33 years of operations in cardiac pacing technology. The intimation was signed by Rupali Ahire, Company Secretary, on 16th May, 2026.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-6.62%	-7.37%	-7.96%	-52.74%	+78.00%	+1,006.27%

Shree Pacetronix Ltd. has received listing approval from BSE Ltd. for 75,150 equity shares of Rs. 10/- each, issued at a premium of Rs. 71/- to Mr. Akash Sethi, the promoter of the company, on a preferential basis pursuant to the conversion of a warrant. The intimation was made on May 07, 2026, in accordance with Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Details of the Listing Approval

The listing approval covers shares bearing distinctive numbers from 3674551 to 3749700. The following table summarises the key parameters of the approved issuance:

Parameter:	Details
Number of Shares:	75,150 equity shares
Face Value:	Rs. 10/- per share
Issue Premium:	Rs. 71/- per share
Allottee:	Mr. Akash Sethi (Promoter)
Basis of Issue:	Preferential allotment via warrant conversion
Distinctive Numbers:	3674551 to 3749700
Listing Exchange:	BSE Ltd.
Date of Approval:	May 07, 2026

Compliance and Trading Approval Requirements

BSE Ltd. has stipulated that trading approval for the aforementioned shares will be granted only upon fulfilment of specific conditions. The company is required to submit the following documents to the exchange:

Listing approval from the National Stock Exchange of India Ltd. (if applicable)
Confirmation letters from NSDL/CDSL confirming the crediting of shares to respective beneficiary accounts or admission of capital to the depository system
Confirmation letters from NSDL/CDSL regarding lock-in of pre-preferential holding (if applicable)

Furthermore, as per Schedule XIX of SEBI (ICDR) Regulations and SEBI circular no. SEBI/HO/CFD/PoD-2/P/CIR/2023/00094 dated June 21, 2023, Shree Pacetronix is required to make an application for trading approval to the stock exchange within seven working days from the date of grant of listing approval. Non-compliance with this requirement will attract fines as specified in the aforementioned SEBI circular.

Shareholding Pattern Disclosure

BSE Ltd. has also noted that in the event the issuance results in a change exceeding two per cent of the total paid-up share capital of the company, Shree Pacetronix will be required to file the shareholding pattern in XBRL mode as mandated under Regulation 31(1)(c) of SEBI LODR Regulations, 2015. The company has also been directed to ensure compliance with the provisions of Regulation 167 of SEBI (ICDR) Regulations and as specified by SEBI from time to time.

The listing approval letter was issued by Marian D'souza, Assistant Vice President, and Mayuri Visaria, Deputy Manager, at BSE Ltd., under reference number LOD/PREF/MV/FIP/192/2026-27. The intimation on behalf of Shree Pacetronix was signed by Rupali Ahire, Company Secretary, on May 07, 2026.